Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Allergan plc News

Glaxo Rises as Elliott Takes Hefty Stake in Drugmaker

The size of Elliott's stake in Glaxo wasn't disclosed. Elliott is headed by iconic investor Paul Singer. Glaxo's shares rose.

AbbVie Reportedly Plans to Sell $5 Billion Women's Drugs Unit

AbbVie is in talks to sell its women's drug business, which makes the Lo Loestrin Fe birth control pill, in an auction, according to Reuters.

Amazon Is Clearly What Hedge Funds Are Betting On These Days

Amazon is perhaps the ultimate all-weather company, and hedge funds have poured into the stock.

AbbVie Is a Buy as Allergan Deal Closes - A Look at the Charts

AbbVie is rallying now that the company has closed its mega-deal with Allergan. The stock is looking to possibly test 2020 highs.

Stock Market Today With Jim Cramer: Oil Prices Go Negative

Jim Cramer discusses the stock market today including the collapse of the oil market, the cannabis stock sector and AbbVie potentially trending up.

Breaking News

FTX Reportedly Close to Buying BlockFi

An acquisition could take several months to close, and the price could shift between now and Friday.

Morningstar's Five Coping Mechanisms for Bear Market

The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?

Economist Roubini: Why Stocks Poised for 50% Wipeout

The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.

Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?

The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.